Taweesin Visanuyothin M.D., Director-General of the Department of Medical Services, together with Sakarn Bunnag M.D., Deputy Director-General of the Department of Medical Services, and Suthat Chottanapund M.D., Deputy Director-General of the Department of Disease Control, held a press conference on the current COVID-19 situation and treatment guidelines. Taweesin Visanuyothin M.D., stated that Mr.Somsak Thepsuthin, Minister of Public Health, is concerned about the increasing number of COVID-19 cases, which may be attributed to the early arrival of the rainy season and the reopening of schools. This period also coincides with a seasonal outbreak of influenza, which presents similar symptoms. The public is therefore being advised to increase self-protection measures.

Currently, a portion of the public has begun to relax their preventive behaviors. However, if everyone cooperates and takes proper precautions, it will help reduce the spread of the virus and lower case numbers. As of 2025, there have been 69 reported deaths, mostly among the "608 group"—senior citizens and individuals with underlying health conditions—mainly in major cities or tourist areas, including Bangkok (22 cases), Chonburi (8), Chanthaburi (7), and Chiang Mai (3). The mortality rate has not increased and stands at 0.106 per 100,000 people, reflecting that the severity of the disease has not worsened.

The overall trend of infections has been on the rise since week 16. During weeks 19–22, case numbers exceeded the five-year average and were higher than during the same period in 2024. In week 22 alone, there were 93,621 new cases—the highest reported so far—while this week has seen 28,392 cases. Disease prevention measures continue to emphasize personal practices, such as social distancing, frequent handwashing, and avoiding crowded places. Although the death rate remains low, high-risk groups (608) must be especially cautious. Additional recommendations include receiving the seasonal influenza vaccine.

Since COVID-19 is no longer classified as a dangerous communicable disease, physicians will determine whether hospitalization or medication is necessary. Currently, hospital admissions for COVID-19 are limited. For example, hospitals under the Department of Medical Services in Bangkok have only 7 inpatients, with over 50 beds still available. The main treatments for severe or high-risk patients remain remdesivir and Paxlovid. According to reports from hospitals, medications can still be procured directly from pharmaceutical companies without shortages. Additionally, the Government Pharmaceutical Organization (GPO) is producing molnupiravir for patients with moderate symptoms or early lung involvement to ensure drug availability.

Source:

Department of Disease Control

ArokaGO Health Library Coronavirus Disease 2019 covid-19 symptoms